Contineum Therapeutics, Inc. - CTNM
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Apr 06, 2026 | Chief Scientific Officer | S | D | 4,170.0 | 13.4326 | 56,013.94 | 147,712.0 | View | |
| Mar 02, 2026 | Chief Scientific Officer | S | D | 4,170.0 | 15.0084 | 62,585.03 | 151,882.0 | View | |
| Mar 02, 2026 | CMO & Head of Development | M | D | 3,611.0 | 0.0 | 0.0 | 249,167.0 | View | |
| Mar 02, 2026 | CMO & Head of Development | S | D | 3,611.0 | 15.0153 | 54,220.25 | 0.0 | View | |
| Mar 02, 2026 | CMO & Head of Development | M | A | 3,611.0 | 4.5 | 16,249.5 | 3,611.0 | View | |
| Feb 26, 2026 | CEO and President | M | D | 2,700.0 | 0.0 | 0.0 | 120,917.0 | View | |
| Feb 26, 2026 | CEO and President | M | D | 4,400.0 | 0.0 | 0.0 | 123,617.0 | View | |
| Feb 26, 2026 | CEO and President | S | D | 2,700.0 | 16.0155 | 43,241.85 | 14,954.0 | View | |
| Feb 26, 2026 | CEO and President | M | A | 2,700.0 | 1.26 | 3,402.0 | 17,654.0 | View | |
| Feb 26, 2026 | CEO and President | S | D | 4,400.0 | 16.0195 | 70,485.8 | 14,954.0 | View | |
| Feb 26, 2026 | CEO and President | M | A | 4,400.0 | 1.26 | 5,544.0 | 19,354.0 | View | |
| Feb 26, 2026 | Chief Scientific Officer | M | D | 3,824.0 | 0.0 | 0.0 | 67,306.0 | View | |
| Feb 26, 2026 | Chief Scientific Officer | M | D | 4,300.0 | 0.0 | 0.0 | 71,130.0 | View | |
| Feb 26, 2026 | Chief Scientific Officer | S | D | 3,824.0 | 16.0115 | 61,227.98 | 156,052.0 | View | |
| Feb 26, 2026 | Chief Scientific Officer | M | A | 3,824.0 | 1.01 | 3,862.24 | 159,876.0 | View | |
| Feb 26, 2026 | Chief Scientific Officer | S | D | 4,300.0 | 16.0316 | 68,935.88 | 156,052.0 | View | |
| Feb 26, 2026 | Chief Scientific Officer | M | A | 4,300.0 | 1.01 | 4,343.0 | 160,352.0 | View | |
| Feb 20, 2026 | Chief Scientific Officer | M | D | 100.0 | 0.0 | 0.0 | 75,430.0 | View | |
| Feb 20, 2026 | Chief Scientific Officer | S | D | 100.0 | 16.0 | 1,600.0 | 156,052.0 | View | |
| Feb 20, 2026 | Chief Scientific Officer | M | A | 100.0 | 1.01 | 101.0 | 156,152.0 | View | |
| Feb 13, 2026 | CEO and President | M | D | 400.0 | 0.0 | 0.0 | 128,017.0 | View | |
| Feb 13, 2026 | CEO and President | S | D | 400.0 | 16.0 | 6,400.0 | 14,954.0 | View | |
| Feb 13, 2026 | CEO and President | M | A | 400.0 | 1.26 | 504.0 | 15,354.0 | View | |
| Feb 13, 2026 | Chief Scientific Officer | M | D | 400.0 | 0.0 | 0.0 | 75,530.0 | View | |
| Feb 13, 2026 | Chief Scientific Officer | S | D | 400.0 | 16.0 | 6,400.0 | 156,052.0 | View | |
| Feb 13, 2026 | Chief Scientific Officer | M | A | 400.0 | 1.01 | 404.0 | 156,452.0 | View | |
| Feb 05, 2026 | Chief Scientific Officer | S | D | 1,170.0 | 15.2451 | 17,836.77 | 156,052.0 | View | |
| Feb 05, 2026 | Chief Scientific Officer | S | D | 3,000.0 | 14.8229 | 44,468.7 | 157,222.0 | View | |
| Jan 30, 2026 | CMO & Head of Development | A | A | 160,000.0 | 0.0 | 0.0 | 160,000.0 | View | |
| Jan 30, 2026 | CMO & Head of Development | M | D | 3,611.0 | 0.0 | 0.0 | 252,778.0 | View | |
| Jan 30, 2026 | CMO & Head of Development | S | D | 811.0 | 14.4848 | 11,747.17 | 0.0 | View | |
| Jan 30, 2026 | CMO & Head of Development | S | D | 2,800.0 | 14.0861 | 39,441.08 | 811.0 | View | |
| Jan 30, 2026 | CMO & Head of Development | M | A | 3,611.0 | 4.5 | 16,249.5 | 3,611.0 | View | |
| Jan 30, 2026 | Chief Scientific Officer | A | A | 6,500.0 | 0.0 | 0.0 | 6,500.0 | View | |
| Jan 30, 2026 | Chief Scientific Officer | A | A | 160,000.0 | 0.0 | 0.0 | 160,000.0 | View | |
| Jan 30, 2026 | CEO and President | A | A | 445,000.0 | 0.0 | 0.0 | 445,000.0 | View | |
| Jan 30, 2026 | Chief Financial Officer | A | A | 192,000.0 | 0.0 | 0.0 | 192,000.0 | View | |
| Jan 30, 2026 | General Counsel and Corp Sec | A | A | 206,411.0 | 0.0 | 0.0 | 206,411.0 | View | |
| Jan 06, 2026 | Chief Scientific Officer | S | D | 500.0 | 11.1298 | 5,564.9 | 160,222.0 | View | |
| Jan 06, 2026 | Chief Scientific Officer | S | D | 3,670.0 | 10.3483 | 37,978.26 | 160,722.0 | View | |
| Dec 30, 2025 | CMO & Head of Development | M | D | 3,611.0 | 0.0 | 0.0 | 256,389.0 | View | |
| Dec 30, 2025 | CMO & Head of Development | S | D | 3,611.0 | 12.0627 | 43,558.41 | 0.0 | View | |
| Dec 30, 2025 | CMO & Head of Development | M | A | 3,611.0 | 4.5 | 16,249.5 | 3,611.0 | View | |
| Dec 30, 2025 | Chief Scientific Officer | S | D | 4,170.0 | 12.2324 | 51,009.11 | 164,392.0 | View |